(Q38884705)

English

Pathological, clinical and prognostic characteristics of breast cancer in Central Sudan versus Northern Italy: implications for breast cancer in Africa

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Pathological, clinical and prognostic characteristics of breast cancer in Central Sudan versus Northern Italy: implications for breast cancer in Africa (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

Renato Mariani-Costantini

object named as

R Mariani-Costantini

10

0 references

author name string

K D Awadelkarim

1

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

C Arizzi

2

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

E O M Elamin

3

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

H M A Hamad

4

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

P De Blasio

5

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

S O Mekki

6

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

I Osman

7

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

I Biunno

8

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

N E Elwali

9

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

M C Barberis

11

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

publication date

1 March 2008

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

52

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

445-456

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Cancer survival in Kampala, Uganda

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.02966.X

21 January 2018

Cancer? In Africa?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.02966.X

21 January 2018

Do we bear any moral responsibility for improving cancer care in Africa?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.02966.X

21 January 2018

A study of patients who appear with far advanced cancer at Yaounde General Hospital, Cameroon, Africa

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.02966.X

21 January 2018

Rural women's perception of breast cancer and its early-detection measures in Ibadan, Nigeria.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.02966.X

21 January 2018

Cancer survival in a southern African urban population

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.02966.X

21 January 2018

The severity, outcome and challenges of breast cancer in Nigeria

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.02966.X

21 January 2018

Breast cancer in sub-Saharan Africa: how does it relate to breast cancer in African-American women?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.02966.X

21 January 2018

Case-control study of risk factors for breast cancer in Nigerian women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.02966.X

21 January 2018

Rates for breast cancer characteristics by estrogen and progesterone receptor status in the major racial/ethnic groups

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.02966.X

21 January 2018

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.02966.X

21 January 2018

Molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.02966.X

21 January 2018

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.02966.X

21 January 2018

Repeated observation of breast tumor subtypes in independent gene expression data sets

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.02966.X

21 January 2018

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.02966.X

21 January 2018

Effects of estrogen receptor expression and histopathology on annual hazard rates of death from breast cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.02966.X

21 January 2018

Progesterone Receptor Status Significantly Improves Outcome Prediction Over Estrogen Receptor Status Alone for Adjuvant Endocrine Therapy in Two Large Breast Cancer Databases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.02966.X

21 January 2018

HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: a southwest oncology group study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.02966.X

21 January 2018

Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.02966.X

21 January 2018

Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.02966.X

21 January 2018

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.02966.X

21 January 2018

Pre-operative systemic (neo-adjuvant) therapy with trastuzumab and docetaxel for HER2-overexpressing stage II or III breast cancer: results of a multicenter phase II trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.02966.X

21 January 2018

Prognostic markers in triple-negative breast cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.02966.X

21 January 2018

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.02966.X

21 January 2018

Gene expression profiling predicts clinical outcome of breast cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.02966.X

21 January 2018

BRCA1 and BRCA2 status in a Central Sudanese series of breast cancer patients: interactions with genetic, ethnic and reproductive factors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.02966.X

21 January 2018

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.02966.X

21 January 2018

Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.02966.X

21 January 2018

Study of interlaboratory reliability and reproducibility of estrogen and progesterone receptor assays in Europe. Documentation of poor reliability and identification of insufficient microwave antigen retrieval time as a major contributory element of

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.02966.X

21 January 2018

Pathobiologic identification of two distinct breast carcinoma subsets with diverging clinical behaviors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.02966.X

21 January 2018

Primary systemic chemotherapy of invasive lobular carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.02966.X

21 January 2018

Histopathology of breast cancer among African-American women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.02966.X

21 January 2018

Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.02966.X

21 January 2018

Childbearing in five Arab countries

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.02966.X

21 January 2018

Oestrogen receptor negative-progesterone receptor positive phenotype in 1,211 breast tumours

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.02966.X

21 January 2018

Molecular classification and molecular forecasting of breast cancer: ready for clinical application?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.02966.X

21 January 2018

Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.02966.X

21 January 2018

Identifiers

10.1111/J.1365-2559.2008.02966.X

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38884705&oldid=1793462033"